SiVEC Biotechnologies, Inc. filed a Form D with the Securities and Exchange Commission on 2025-09-17.
SiVEC Biotechnologies, Inc. filed a Form D notice of an exempt securities offering with the SEC on September 17, 2025. The filing reports $3.30M sold. Its industry group is Biotechnology. It names Lyndsey Linke (Executive Officer, Director), Darcy Mora (Executive Officer, Director), Richard Freed III (Director) (SEC Form D, September 17, 2025).
Is this your company?
Sell to companies like SiVEC Biotechnologies, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-09-17 · the record
Pitching, partnering or investing alongside them? See who really runs and owns SiVEC Biotechnologies, Inc.
Free to see. No signup.
More on the people and the money behind SiVEC Biotechnologies, Inc., from the filings we hold.
Biotechnology raises by companies based in Colorado, filed within 90 days of this one, largest first.
Get an email when SiVEC Biotechnologies, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when SiVEC Biotechnologies, Inc. raises, hires or launches. No email unless you switch it on.
Watch SiVEC Biotechnologies, Inc. →Get the full cited report on SiVEC Biotechnologies, Inc.
What the filing shows about SiVEC Biotechnologies, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on SiVEC Biotechnologies, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives SiVEC Biotechnologies, Inc.'s address as 1505 West Mulberry Street, Fort Collins, CO 80521.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on SiVEC Biotechnologies, Inc. See pricing
SiVEC Biotechnologies, Inc. is a registered filer with the SEC (CIK 2085969) and has filed since 2025-09-17. 1 filing is on record, the latest on 2025-09-17.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
SiVEC Biotechnologies, Inc.'s Form D of 2025-09-17 names Lyndsey Linke, Darcy Mora, Richard Freed III and 2 more as its officers, directors or promoters.
Its new offerings report $3.30M sold across 1 offering, as its own filings state.
Trailing twelve months. 766 filings in Biotechnology, totalled by week.
Lyndsey Linke is named as Executive Officer and Director on the Form D that SiVEC Biotechnologies, Inc. filed with the SEC on 17 September 2025, one of 5 people that filing names.
Darcy Mora is named as Executive Officer and Director on the Form D that SiVEC Biotechnologies, Inc. filed with the SEC on 17 September 2025, one of 5 people that filing names.
Richard Freed III is named as Director on the Form D that SiVEC Biotechnologies, Inc. filed with the SEC on 17 September 2025, one of 5 people that filing names.
Sibylle Hauser is named as Director on the Form D that SiVEC Biotechnologies, Inc. filed with the SEC on 17 September 2025, one of 5 people that filing names.
David Sherris is named as Director on the Form D that SiVEC Biotechnologies, Inc. filed with the SEC on 17 September 2025, one of 5 people that filing names.
5 people named on the filing — 2 holding an executive role and 3 as directors only.
Named as of the 2025-09-17 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about SiVEC Biotechnologies, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on SiVEC Biotechnologies, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on SiVEC Biotechnologies, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist SiVEC Biotechnologies, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind SiVEC Biotechnologies, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for SiVEC Biotechnologies, Inc.. With no account yet, you sign up free and land on the result.
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/sivec-biotechnologies-inc-form-d-25000001